Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3928studies shown
Showing 1,676-1,700 of 3,928
RecruitingNCT06917339

Retrospective Analyses of TrakStar Database

This observational study is following people with Depression, Obsessive-Compulsive Disorder, or anxiety or depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 5 Years to 120 Years
Countries
United States
Sponsor
Neuronetics
Condition
Depression
Active Not RecruitingNCT07164287

Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment

This study is looking at assess the effects of psychedelic-assisted psychotherapy with LSD or psilocybin on changes in depressive symptoms, anxiety symptoms for people with depression, anxiety, Substance Use Disorder, or PTSD - Post Traumatic Stress Disorder. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionDrugOver 18 Years
Countries
Switzerland
Sponsor
University Hospital, Geneva
Condition
Depression
RecruitingNCT06080646

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

This observational study is following people with major depression Depressive Episode, Depressive Symptoms, or Anhedonia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
San Francisco Veterans Affairs Medical Center
Condition
Depression
RecruitingNCT06675851

Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People

This study is comparing WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline with Healthy Controls without antidepressant intake for people with depression. Participants receive WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline or Healthy Controls without antidepressant intake and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Depression
Not Yet RecruitingNCT06491069

Risk Factors of Depression, Anxiety and Eating Disorder After Bariatric Surgery

This study is looking at Investigate and determine rate of occurrence and associated risk factors of depression, anxiety, eating disorder after bariatric surgery for people with Depression, Anxiety, Eating Disorders, or Bariatric Surgery. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 60 Years
Countries
Global
Sponsor
Sohag University
Condition
Depression
RecruitingNCT05527509

Risk and Resiliency Factors in the RCMP: A Prospective Investigation

This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionBehavioralFrom 19 Years to 57 Years
Countries
Canada
Sponsor
University of Regina
Condition
Depression
UnknownNCT06042972

Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines

This observational study is following people with Post Partum Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre Médical Porte Verte
Condition
Depression
Not Yet RecruitingNCT07460063

Routine vs. Early Postpartum Depression Screening: A Pragmatic Clinical Trial

This observational study is looking at how a digital support tool works for people with Postpartum Depression in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherOver 18 Years
Countries
Global
Sponsor
Massachusetts General Hospital
Condition
Depression
RecruitingNCT06917950

Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients

This study is looking at investigate if Roxadustat has effects beyond treating anemia in hemodialysis patients for people with Kidney Failure,Chronic, Anemia in End Stage Renal Disease, or Depression anxiety. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDrugOver 18 Years
Countries
Egypt
Sponsor
Mansoura University
Condition
Depression
RecruitingNCT05591937

S.T.A.N.D. Alacrity Center Signature Project

This study is looking at whether cognitive behavioural therapy can help people with Depression or Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.

AnxietyOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Anxiety
RecruitingNCT07210255

SAINT in Postpartum Depression (PPD)

This study is comparing SAINT Neuromodulation System with Sham SAINT Stimulation for people with Postpartum Depression. Participants receive SAINT Neuromodulation System or Sham SAINT Stimulation and complete study visits and assessments.

DepressionOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Magnus Medical
Condition
Depression
Active Not RecruitingNCT05388110

SKY Breath Intervention

This observational study is following people with Depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionBehavioralFrom 16 Years to 24 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
RecruitingNCT07136584

SOS for Caregiver Wellbeing

This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOther
Countries
Australia
Sponsor
Murdoch Childrens Research Institute
Condition
Depression
RecruitingNCT07174947

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

This study is comparing Fluoxetine (drug) with placebo for people with Hepatobiliary Malignancy, Fluoxetine, anxiety, or Depression Disorders. Participants receive Fluoxetine (drug) or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 80 Years
Countries
China
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Condition
Depression
RecruitingNCT06324864

START NOW Adapted: Culturally Adapted Version of START NOW

This study is looking at whether START NOW Adapted can help people with depression or anxiety. Participants take part in START NOW Adapted and complete follow-up assessments.

AnxietyOtherFrom 14 Years to 18 Years
Countries
Switzerland
Sponsor
Prof. Christina Stadler
Condition
Anxiety
RecruitingNCT07186816

SUpport From PEeRs to Expand Access Study - Community

This study is looking at whether Behavioral: Supported dCBT can help people with Depression, Anxiety. Participants take part in Behavioral: Supported dCBT and complete follow-up assessments.

DepressionDeviceFrom 18 Years to 100 Years
Countries
United States
Sponsor
University of California, Berkeley
Condition
Depression
RecruitingNCT04752618

Safe Mothers, Safe Children Initiative

This study is looking at whether P-STAIR can help people with Ptsd, Depression, or Child Maltreatment. Participants take part in P-STAIR and complete follow-up assessments.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
New York University
Condition
Depression
UnknownNCT04834427

Safety and Efficacy Evaluation of S (+) - Ketamine in Children

This study is comparing Conventional therapy + S (+)-Ketamine with Control group for people with depression or anxiety. Participants receive Conventional therapy + S (+)-Ketamine or Control group and complete study visits and assessments.

DepressionDrugUp to 17 Years
Countries
China
Sponsor
Chinese PLA General Hospital
Condition
Depression
Enrolling By InvitationNCT07345858

Salivary Oxytocin as a Biomarker of Psychedelic Treatment

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherOver 18 Years
Countries
Switzerland
Sponsor
University of Geneva, Switzerland
Condition
Depression
Depression | Clinical Trials | HopeStage Research